Table 1

Clinical features (n = 43)
Contents Patients
NO. %
Sex
  Male 39 90.7
  Female 4 9.3
Age (years)
  Range

2-18

10.3

9

  Mean
  Median
Sites
  abdomen 20 46.5
  Jaws and facial bones 7 16.3
  superficial lymph node 7 16.3
  tonsils 3 7.0
  nasopharynx 3 7.0
  inner canthus 1 2.3
  cerebellum 1 2.3
  peripheral blood & bone marrow 1 2.3
B symptom 17 39.5
Bulky disease
  <10 cm 35 81.4
  ≥10 cm 7 16.3
Lab findings (n = 34)
  anemia 18 52.9
  Increased WBC count 12 35.3
  Increased PLT number 21 61.8
  Increased serum level of LDH 23 67.6
Staging (n = 43, Jude and Murphy)
  I / II 8/20 19.1/47.6
  III / IV 9/6 21.4/11.9
IPI (n = 34)
  Low (0–2) 24 70.6
  High (3–4) 10 29.4
Therapy (n = 30)
  Surgery alone 10 33.3
  Chemotherapy alone 11 36.7
  Surgery and chemotherapy 9 30
Follow up (n = 43, months)
  Dead 27 62.8 (average 4.9 m)
  Alive 16 37.2 (average 48.7 m)

Bi et al.

Bi et al. Diagnostic Pathology 2012 7:72   doi:10.1186/1746-1596-7-72

Open Data